AR023389A1 - Nuevo uso - Google Patents

Nuevo uso

Info

Publication number
AR023389A1
AR023389A1 ARP000101558A ARP000101558A AR023389A1 AR 023389 A1 AR023389 A1 AR 023389A1 AR P000101558 A ARP000101558 A AR P000101558A AR P000101558 A ARP000101558 A AR P000101558A AR 023389 A1 AR023389 A1 AR 023389A1
Authority
AR
Argentina
Prior art keywords
new use
headache
treatment
low affinity
nmda antagonists
Prior art date
Application number
ARP000101558A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023389A1 publication Critical patent/AR023389A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

El uso de antagonistas de NMDA de baja afinidad, para el tratamiento del dolor de cabeza.
ARP000101558A 1999-04-06 2000-04-05 Nuevo uso AR023389A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (sv) 1999-04-06 1999-04-06 Novel use

Publications (1)

Publication Number Publication Date
AR023389A1 true AR023389A1 (es) 2002-09-04

Family

ID=20415133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101558A AR023389A1 (es) 1999-04-06 2000-04-05 Nuevo uso

Country Status (4)

Country Link
AR (1) AR023389A1 (es)
AU (1) AU3994100A (es)
SE (1) SE9901237D0 (es)
WO (1) WO2000059496A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0356035B1 (en) * 1988-08-12 1996-03-13 Astra Aktiebolag Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
ES2122098T3 (es) * 1991-02-28 1998-12-16 Merrell Pharma Inc Antagonistas del nmda.
PL180014B1 (pl) * 1992-04-03 2000-11-30 Astra Ab (S)- a-fenylo-2-pirydoetanoamina i kompozycja farmaceutyczna zawierajaca (S)- a-fenylo-2-pirydoetanoamine PL PL PL PL PL PL
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
IS4233A (is) * 1993-12-22 1995-06-23 Astra Aktiebolag Misleit hringtengd efnasambönd
DE19510189A1 (de) * 1995-03-21 1996-09-26 Hartmut Dr Goebel Verwendung von Amantadin
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
CA2270531C (en) * 1996-11-05 2011-08-30 Head Explorer Aps A method for treating tension-type headache

Also Published As

Publication number Publication date
SE9901237D0 (sv) 1999-04-06
AU3994100A (en) 2000-10-23
WO2000059496A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
BR0114829A (pt) Novos compostos
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DE69728585D1 (de) Mittel gegen Juckreiz
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
MXPA03007140A (es) Derivados de carbolina.
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
BR9706934A (pt) Novos compostos de imidazol substituìdo
UY27079A1 (es) Procedimiento para la preparación de un anticolinérgico
UY28342A1 (es) Nuevos compuestos
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
BR0215405A (pt) Composições e processos de uso de collajolie
UY27098A1 (es) Derivados de indol
DE69905170T2 (de) Thiazolopyrimidinderivate
UY28348A1 (es) Compuestos novedosos
DE60216233D1 (en) Carbolinderivate
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
AR016981A2 (es) Polipeptidos sinteticos
BR0309053A (pt) Compostos
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
SE0301650D0 (sv) Novel compounds
ATE302776T1 (de) Kondensierte pyridoindolderivate
ES2175798T3 (es) Cd8 como un inhibidor del sistema inmunitario celular.
BR0206917A (pt) Uso de antagonistas de mglur5 para o tratamento de condições prurìticas
AR023389A1 (es) Nuevo uso